Ballarat Health Services

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials
• Lung cancer2 trials
• Acute myeloid leukaemia1 trial
• Brain metastases1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Kidney cancer1 trial
• Mantle cell lymphoma1 trial
• Melanoma1 trial
• and 2 more

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting4 trials

Lead sponsor

• Canadian Cancer Trials Group1 trial
• EMD Serono Research & Development Institute, Inc.1 trial
• HUYABIO International, LLC.1 trial
• Pharmacyclics Switzerland GmbH1 trial

Running trials

• Active, not recruiting

  Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

  NCT04674683· Phase 3· HUYABIO International, LLC.· Source

• Active, not recruiting

  Avelumab Program Rollover Study

  NCT03815643· Phase 3· EMD Serono Research & Development Institute, Inc.· Source

• Active, not recruiting

  Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  NCT03229200· Phase 4· Pharmacyclics Switzerland GmbH· Source

• Active, not recruiting

  Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

  NCT03057106· Phase 2· Canadian Cancer Trials Group· Source